Live Feeds
● LIVE Updated 9d ago · 15 sources tracked

Which GLP-1 works best? New meta-study puts them head-to-head

A new meta-analysis from the University of Georgia compared the effectiveness of tirzepatide, semaglutide, and liraglutide for weight loss. The data indicates tirzepatide may be the most effective option for non-diabetic patients. Tirzepatide is marketed under the brand names Zepbound and Mounjaro.

RSS Source map (17)

What changed

A University of Georgia meta-analysis and head-to-head trials have identified tirzepatide as more effective for weight loss than semaglutide.

Live updates

  1. University of Georgia Meta-Analysis Compares GLP-1 Weight Loss Efficacy

    A new meta-analysis from the University of Georgia compared the effectiveness of tirzepatide, semaglutide, and liraglutide for weight loss. The data indicates tirzepatide may be the most effective option for non-diabetic patients. Tirzepatide is marketed under the brand names Zepbound and Mounjaro.

    What's confirmed:

    • A University of Georgia meta-analysis compared tirzepatide, semaglutide, and liraglutide.
    • Tirzepatide is sold under the brand names Zepbound and Mounjaro.
    • Semaglutide is sold as Wegovy and Ozempic.
    • Liraglutide is known as Saxenda and Victoza.
    • Tirzepatide outperforms semaglutide for real-world weight loss.
    • Zepbound beat Wegovy in the first head-to-head trial comparing the two obesity drugs.
    • For non-diabetic patients, tirzepatide may be the most effective GLP-1 medication.

    Still unconfirmed:

    • Setting a goal weight may lead to greater success with GLP-1s like Zepbound.
    confidence 95%